Jacob Chacko - Dec 15, 2022 Form 4/A - Amendment Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
President and CEO, Director
Signature
/s/ Christian Kuhlen, attorney-in-fact
Stock symbol
ORIC
Transactions as of
Dec 15, 2022
Transactions value $
-$18,859
Form type
4/A - Amendment
Date filed
2/17/2023, 03:22 PM
Date Of Original Report
Dec 16, 2022
Previous filing
Jul 21, 2022
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Sale -$18.9K -6.14K -0.75% $3.07 817K Dec 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is filed to correct the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person.